SPONSOR
Vanda Pharmaceuticals
Total Trials
3
Recruiting
3
Phases
Phase 3
Conditions studied: Nausea and VomitingObesityModerate-to-severe Chronic Plaque PsoriasisUlcerative Colitis (UC)
Vanda Pharmaceuticals is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Nausea and Vomiting, Obesity, Moderate-to-severe Chronic Plaque Psoriasis, Ulcerative Colitis (UC).
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Vanda Pharmaceuticals
How many clinical trials has Vanda Pharmaceuticals sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Vanda Pharmaceuticals, of which 3 are actively recruiting participants. These trials cover conditions including Nausea and Vomiting, Obesity, Moderate-to-severe Chronic Plaque Psoriasis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Vanda Pharmaceuticals research focus on?
Vanda Pharmaceuticals clinical trials span Nausea and Vomiting, Obesity, Moderate-to-severe Chronic Plaque Psoriasis, Ulcerative Colitis (UC). The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Vanda Pharmaceuticals clinical trial?
To participate in a Vanda Pharmaceuticals trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Vanda Pharmaceuticals trials with current recruitment status updated daily.
Clinical Trials by Vanda Pharmaceuticals
NCT07446439 Phase 3
Recruiting
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
Nausea and Vomiting
NCT07362017 Phase 3
Recruiting
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
Moderate-to-severe Chronic Plaque Psoriasis
NCT07686081 Phase 3
Recruiting
Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology